These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24759667)

  • 1. Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery.
    Rawlins SR; Mullen CM; Simon HM; Kim T; Landas SK; Walser MS; Levine RA
    Gastroenterol Rep (Oxf); 2013 Jul; 1(1):51-7. PubMed ID: 24759667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
    Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of wedge and needle hepatic biopsy in open bariatric surgery.
    Padoin AV; Mottin CC; Moretto M; Berleze D; Kupski C; Glock L; Reichel CL; da Silva VD; da Silva JB
    Obes Surg; 2006 Feb; 16(2):178-82. PubMed ID: 16469220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the histological variability of core and wedge biopsies in nonalcoholic fatty liver disease in bariatric surgical patients.
    Ooi GJ; Clouston A; Johari Y; Kemp WW; Roberts SK; Brown WA; Burton PR
    Surg Endosc; 2021 Mar; 35(3):1210-1218. PubMed ID: 32170564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies.
    Janiec DJ; Jacobson ER; Freeth A; Spaulding L; Blaszyk H
    Obes Surg; 2005 Apr; 15(4):497-501. PubMed ID: 15946428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUS-guided left lobe liver biopsy: Safer modality with similar diagnostic yield as right lobe: a pilot study.
    Sharma M; Lakhtakia S; Jagtap N; Sekaran A; Kalapala R; Jahangeer B; Kulkarni A; Ramchandani M; Gupta R; Samudraala S; Khanna J; Nagaraja P; Iyengar S; Gora BA; Rao GV; Reddy N
    Endosc Int Open; 2023 Feb; 11(2):E172-E178. PubMed ID: 36845273
    [No Abstract]   [Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.
    Clark JM; Alkhuraishi AR; Solga SF; Alli P; Diehl AM; Magnuson TH
    Obes Res; 2005 Jul; 13(7):1180-6. PubMed ID: 16076987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery.
    Gholam PM; Kotler DP; Flancbaum LJ
    Obes Surg; 2002 Feb; 12(1):49-51. PubMed ID: 11868297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
    Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
    Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation.
    Jun MJ; Shim JH; Kim SY; Seo N; Kim KM; Lim YS; Lee HC; Yu E; Lee SG
    Liver Transpl; 2014 Apr; 20(4):437-45. PubMed ID: 24478019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
    Merriman RB; Ferrell LD; Patti MG; Weston SR; Pabst MS; Aouizerat BE; Bass NM
    Hepatology; 2006 Oct; 44(4):874-80. PubMed ID: 17006934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.
    Barker KB; Palekar NA; Bowers SP; Goldberg JE; Pulcini JP; Harrison SA
    Am J Gastroenterol; 2006 Feb; 101(2):368-73. PubMed ID: 16454845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients.
    Vargas V; Allende H; Lecube A; Salcedo MT; Baena-Fustegueras JA; Fort JM; Rivero J; Ferrer R; Catalán R; Pardina E; Ramón Y Cajal S; Guardia J; Peinado-Onsurbe J
    World J Hepatol; 2012 Dec; 4(12):382-8. PubMed ID: 23355916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver histology abnormalities in the morbidly obese.
    Klain J; Fraser D; Goldstein J; Peiser J; Avinoah E; Ovnat A; Charuzi I
    Hepatology; 1989 Nov; 10(5):873-6. PubMed ID: 2807169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies.
    Pedersen JS; Rygg MO; Serizawa RR; Kristiansen VB; Albrechtsen NJW; Gluud LL; Madsbad S; Bendtsen F
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of hepatic steatosis in morbidly obese persons after gastric bypass.
    Silverman EM; Sapala JA; Appelman HD
    Am J Clin Pathol; 1995 Jul; 104(1):23-31. PubMed ID: 7611176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
    Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
    Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
    Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
    Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of different grades of nonalcoholic fatty liver disease.
    Júnior WS; Nonino-Borges CB
    Obes Surg; 2012 Feb; 22(2):248-52. PubMed ID: 21598007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.